前列腺癌中当前的干细胞生物标志物及其功能机制
Current Stem Cell Biomarkers and Their Functional Mechanisms in Prostate Cancer.
作者信息
Zhang Kaile, Zhou Shukui, Wang Leilei, Wang Jianlong, Zou Qingsong, Zhao Weixin, Fu Qiang, Fang Xiaolan
机构信息
The Department of Urology, Affiliated Sixth People's Hospital, Shanghai JiaoTong University, Shanghai 200233, China.
Wake Forest Institute for Regenerative Medicine, Winston-Salem, NC 27101, USA.
出版信息
Int J Mol Sci. 2016 Jul 19;17(7):1163. doi: 10.3390/ijms17071163.
Abstract
Currently there is little effective treatment available for castration resistant prostate cancer, which is responsible for the majority of prostate cancer related deaths. Emerging evidence suggested that cancer stem cells might play an important role in resistance to traditional cancer therapies, and the studies of cancer stem cells (including specific isolation and targeting on those cells) might benefit the discovery of novel treatment of prostate cancer, especially castration resistant disease. In this review, we summarized major biomarkers for prostate cancer stem cells, as well as their functional mechanisms and potential application in clinical diagnosis and treatment of patients.
摘要
目前，对于去势抵抗性前列腺癌几乎没有有效的治疗方法，而这种癌症导致了大多数与前列腺癌相关的死亡。新出现的证据表明，癌症干细胞可能在对传统癌症治疗的抵抗中发挥重要作用，对癌症干细胞的研究（包括对这些细胞的特异性分离和靶向）可能有助于发现前列腺癌的新治疗方法，尤其是去势抵抗性疾病的治疗方法。在这篇综述中，我们总结了前列腺癌干细胞的主要生物标志物，以及它们的功能机制和在患者临床诊断与治疗中的潜在应用。
相似文献
1
Current Stem Cell Biomarkers and Their Functional Mechanisms in Prostate Cancer.
Int J Mol Sci. 2016 Jul 19;17(7):1163. doi: 10.3390/ijms17071163.
2
Prostate Cancer Stem Cells: Research Advances.
Int J Mol Sci. 2015 Nov 17;16(11):27433-49. doi: 10.3390/ijms161126036.
3
Prostate cancer stem cells: deciphering the origins and pathways involved in prostate tumorigenesis and aggression.
Oncotarget. 2015 Feb 10;6(4):1900-19. doi: 10.18632/oncotarget.2953.
4
Enrichment of putative prostate cancer stem cells after androgen deprivation: upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines.
Prostate. 2013 Sep;73(13):1378-90. doi: 10.1002/pros.22685. Epub 2013 May 31.
5
Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer.
Clin Cancer Res. 2016 Feb 1;22(3):670-9. doi: 10.1158/1078-0432.CCR-15-0190. Epub 2015 Oct 21.
6
Non-coding RNAs in Prostate Cancer: From Discovery to Clinical Applications.
Adv Exp Med Biol. 2016;886:155-170. doi: 10.1007/978-94-017-7417-8_8.
7
[Cancer stem cells in prostate cancer].
Nihon Rinsho. 2014 Dec;72(12):2229-33.
8
Androgen receptor and prostate cancer stem cells: biological mechanisms and clinical implications.
Endocr Relat Cancer. 2015 Dec;22(6):T209-20. doi: 10.1530/ERC-15-0217. Epub 2015 Aug 18.
9
Stem cells in prostate cancer initiation and progression.
J Clin Invest. 2007 Aug;117(8):2044-50. doi: 10.1172/JCI32810.
10
Androgen deprivation causes epithelial-mesenchymal transition in the prostate: implications for androgen-deprivation therapy.
Cancer Res. 2012 Jan 15;72(2):527-36. doi: 10.1158/0008-5472.CAN-11-3004. Epub 2011 Nov 22.
引用本文的文献
1
Advances in Prostate Cancer Biomarkers and Probes.
Cyborg Bionic Syst. 2024 Jun 27;5:0129. doi: 10.34133/cbsystems.0129. eCollection 2024.
2
Detection of circulating tumor cells in non-metastatic prostate cancer through integration of a microfluidic CTC enrichment system and multiparametric flow cytometry.
PLoS One. 2024 Oct 23;19(10):e0312296. doi: 10.1371/journal.pone.0312296. eCollection 2024.
3
Induction of promyelocytic leukemia zinc finger protein by miR-200c-3p restores sensitivity to anti-androgen therapy in androgen-refractory prostate cancer and inhibits the cancer progression via down-regulation of integrin α3β4.
Cell Oncol (Dordr). 2023 Aug;46(4):1113-1126. doi: 10.1007/s13402-023-00803-y. Epub 2023 Mar 30.
4
Microbiota-Derived Natural Products Targeting Cancer Stem Cells: Inside the Gut Pharma Factory.
Int J Mol Sci. 2023 Mar 5;24(5):4997. doi: 10.3390/ijms24054997.
5
Liquid biopsy-based targeted gene screening highlights tumor cell subtypes in patients with advanced prostate cancer.
Clin Transl Sci. 2022 Nov;15(11):2597-2612. doi: 10.1111/cts.13372. Epub 2022 Sep 29.
6
The driver role of JAK-STAT signalling in cancer stemness capabilities leading to new therapeutic strategies for therapy- and castration-resistant prostate cancer.
Clin Transl Med. 2022 Aug;12(8):e978. doi: 10.1002/ctm2.978.
7
Role of prostate cancer stem-like cells in the development of antiandrogen resistance.
Cancer Drug Resist. 2022 Jun 1;5(2):459-471. doi: 10.20517/cdr.2022.07. eCollection 2022.
8
Epidermal Growth Factor Is Essential for the Maintenance of Novel Prostate Epithelial Cells Isolated From Patient-Derived Organoids.
Front Cell Dev Biol. 2020 Oct 29;8:571677. doi: 10.3389/fcell.2020.571677. eCollection 2020.
9
Protein Expression Analysis of an In Vitro Murine Model of Prostate Cancer Progression: Towards Identification of High-Potential Therapeutic Targets.
J Pers Med. 2020 Aug 10;10(3):83. doi: 10.3390/jpm10030083.
10
Effect of Tumor Burden on Tumor Aggressiveness and Immune Modulation in Prostate Cancer: Association with IL-6 Signaling.
Cancers (Basel). 2019 Jul 16;11(7):992. doi: 10.3390/cancers11070992.
本文引用的文献
1
Aldehyde dehydrogenase 1 expression correlates with clinicopathologic features of patients with breast cancer: a meta-analysis.
Int J Clin Exp Med. 2015 Jun 15;8(6):8425-32. eCollection 2015.
2
Transglutaminase is a tumor cell and cancer stem cell survival factor.
Mol Carcinog. 2015 Oct;54(10):947-58. doi: 10.1002/mc.22375. Epub 2015 Aug 10.
3
Metformin and prostate cancer stem cells: a novel therapeutic target.
Prostate Cancer Prostatic Dis. 2015 Dec;18(4):303-9. doi: 10.1038/pcan.2015.35. Epub 2015 Jul 28.
4
Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression.
J Oral Pathol Med. 2016 Feb;45(2):89-95. doi: 10.1111/jop.12335. Epub 2015 Jul 25.
5
Inhibition of hedgehog signaling reduces the side population in human malignant mesothelioma cell lines.
Cancer Gene Ther. 2015 Aug;22(8):387-95. doi: 10.1038/cgt.2015.31. Epub 2015 Jul 24.
6
Integration of cell-cell and cell-ECM adhesion in vertebrate morphogenesis.
Curr Opin Cell Biol. 2015 Oct;36:48-53. doi: 10.1016/j.ceb.2015.07.002. Epub 2015 Jul 17.
7
Efficacy of Cabazitaxel in Castration-resistant Prostate Cancer Is Independent of the Presence of AR-V7 in Circulating Tumor Cells.
Eur Urol. 2015 Dec;68(6):939-45. doi: 10.1016/j.eururo.2015.07.007. Epub 2015 Jul 15.
8
Cellular prostatic acid phosphatase (cPAcP) serves as a useful biomarker of histone deacetylase (HDAC) inhibitors in prostate cancer cell growth suppression.
Cell Biosci. 2015 Jul 17;5:38. doi: 10.1186/s13578-015-0033-y. eCollection 2015.
9
Serial blood-based analysis of AR-V7 in men with advanced prostate cancer.
Ann Oncol. 2015 Sep;26(9):1859-1865. doi: 10.1093/annonc/mdv282. Epub 2015 Jun 27.
10
mPGES-1 in prostate cancer controls stemness and amplifies epidermal growth factor receptor-driven oncogenicity.
Endocr Relat Cancer. 2015 Aug;22(4):665-78. doi: 10.1530/ERC-15-0277. Epub 2015 Jun 25.
Zotero 插件